Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Lopez-Rios

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Expert Review of Molecular Diagnostics|January 13, 2015
The anaplastic lymphoma kinase testing conundrumEsther Conde, Philippe Taniere, Fernando Lopez-Rios
Expert Review of Molecular Diagnostics|May 22, 2014
A new generation of companion diagnostics: cobas BRAF, KRAS and EGFR mutation detection testsBarbara Angulo, Fernando Lopez-Rios, David Gonzalez
Journal of Clinical Pathology|June 3, 2020
Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safetyJohn R Gosney, Paul Hofman, Giancarlo Troncone, et al.
Expert Review of Molecular Diagnostics|April 1, 2016
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomasEsther Conde, Susana Hernandez, Mario Prieto, et al.
The European Respiratory Journal|March 4, 2017
Biological therapies in nonsmall cell lung cancerJon Zugazagoitia, Sonia Molina-Pinelo, Fernando Lopez-Rios, et al.
International Journal of Cancer|September 23, 2006
Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lungMoying Tang, Juan Torres-Lanzas, Fernando Lopez-Rios, et al.
Expert Review of Molecular Diagnostics|April 26, 2021
Screening for <i>ROS1</i> fusions in patients with advanced non-small cell lung carcinomas using the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary AntibodyEsther Conde, Susana Hernandez, Amparo Benito, et al.
Journal of Clinical Pathology|October 17, 2024
Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithmsAida Molero, Susana Hernandez, Marta Alonso, et al.
Human Molecular Genetics|February 26, 2005
Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cellsPedro P Medina, Julian Carretero, Esteban Ballestar, et al.
Cancer Research|November 16, 2011
Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancerSandra D Castillo, Ander Matheu, Niccolo Mariani, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Expert Review of Molecular Diagnostics|January 13, 2015
The anaplastic lymphoma kinase testing conundrumEsther Conde, Philippe Taniere, Fernando Lopez-Rios
Expert Review of Molecular Diagnostics|May 22, 2014
A new generation of companion diagnostics: cobas BRAF, KRAS and EGFR mutation detection testsBarbara Angulo, Fernando Lopez-Rios, David Gonzalez
Journal of Clinical Pathology|June 3, 2020
Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safetyJohn R Gosney, Paul Hofman, Giancarlo Troncone, et al.
Expert Review of Molecular Diagnostics|April 1, 2016
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomasEsther Conde, Susana Hernandez, Mario Prieto, et al.
The European Respiratory Journal|March 4, 2017
Biological therapies in nonsmall cell lung cancerJon Zugazagoitia, Sonia Molina-Pinelo, Fernando Lopez-Rios, et al.
International Journal of Cancer|September 23, 2006
Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lungMoying Tang, Juan Torres-Lanzas, Fernando Lopez-Rios, et al.
Expert Review of Molecular Diagnostics|April 26, 2021
Screening for <i>ROS1</i> fusions in patients with advanced non-small cell lung carcinomas using the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary AntibodyEsther Conde, Susana Hernandez, Amparo Benito, et al.
Journal of Clinical Pathology|October 17, 2024
Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithmsAida Molero, Susana Hernandez, Marta Alonso, et al.
Human Molecular Genetics|February 26, 2005
Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cellsPedro P Medina, Julian Carretero, Esteban Ballestar, et al.
Cancer Research|November 16, 2011
Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancerSandra D Castillo, Ander Matheu, Niccolo Mariani, et al.
Pageof 7